The Federal Circuit affirmed the jury’s infringement finding for two of the three patents appealed, but concluded that Blue Coat was entitled to judgment as a matter of law of non-infringement for the third patent. As for the damages award, Blue Coat argued that Finjan failed to appropriately apportion …